BPC-157 Capsules
Price range: 77,00 € through 130,00 €
BPC-157 Capsules
Description
BPC-157 is a synthetic pentadecapeptide derived from a protective sequence found in human gastric juice, composed of 15 amino acids and widely studied for its cytoprotective and regenerative properties. Research has explored its role in tissue repair, angiogenesis, and gastrointestinal protection across multiple experimental models.
In preclinical studies, BPC-157 has been observed to accelerate connective tissue healing, upregulate VEGF expression, and modulate the nitric oxide (NO) pathway to support vascular integrity. Additional research highlights its influence on the gut-brain axis, with reported effects on intestinal barrier function and mucosal regeneration.
Secondary mechanisms include modulation of inflammatory cytokines and interaction with growth factor receptors, contributing to its broad regenerative profile in research models focused on musculoskeletal, gastrointestinal, and neural tissues.
Formulated as pre-dosed oral capsules, this presentation offers a convenient, ready-to-use format for research applications, with consistent strength per capsule and straightforward handling under laboratory conditions.
Clinical Status:
BPC-157 is a research peptide evaluated in numerous animal models and limited human observational studies for gastrointestinal healing, musculoskeletal regeneration, and angiogenic modulation. It is not approved for medical use and remains restricted to experimental and laboratory research.
Evidence type:
Human RCT ☐ | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory ☐
Mechanism of Action
In laboratory models, BPC-157 is reported to interact with several pathways linked to tissue maintenance and repair. Research describes upregulation of the growth-hormone receptor and modulation of nitric oxide signalling, alongside effects on VEGF-driven angiogenesis that may support the formation of new blood vessels. As an orally administered pentadecapeptide, the swallowed capsule is studied for its notable stability in gastric conditions, making it a candidate for investigating gut-associated cytoprotective mechanisms.
Benefits
The following research-reported properties summarise areas where BPC-157 has been examined in preclinical and experimental settings. These observations are drawn primarily from animal and in-vitro studies and are presented for research context only; they describe investigational findings and do not represent therapeutic outcomes or approved indications in humans.
- Gastrointestinal protection: BPC-157 originates from a protective protein identified in gastric juice, and a large body of preclinical work has examined its stabilising effect on the gut lining when challenged with chemical or physical stressors. The oral capsule format is of particular interest in this area, since the swallowed peptide is delivered directly into the gastrointestinal tract, where much of this research activity has historically been localised and where the compound’s reported stability in gastric conditions is most relevant.
- Tissue repair and healing: Experimental models have explored BPC-157 in the context of soft-tissue, tendon, ligament, muscle, and bone repair. Across these models researchers have reported faster organisation of repair tissue, improved structural recovery, and enhanced fibroblast activity in injured animals, which together form the basis of the compound’s widely studied regenerative profile.
- Angiogenesis support: Multiple studies describe upregulation of vascular endothelial growth factor (VEGF) and the promotion of new blood-vessel formation. This angiogenic activity is believed to underlie a substantial part of the compound’s regenerative behaviour in laboratory work, since improved vascular supply supports the delivery of nutrients to repairing tissue.
- Cytoprotection: Across several organ systems, BPC-157 has been characterised as a body-protective compound, with reported stabilising effects on cells exposed to chemical, ischaemic, and physical stressors in controlled experiments. This broad cytoprotective signature is the property from which the compound takes its name.
- Gut-brain and neurological models: Some preclinical literature has examined BPC-157 in nervous-system models, investigating interactions along the gut-brain axis and reporting effects on certain neurotransmitter pathways, including dopaminergic and serotonergic systems in rodents.
- Tendon and bone models: Research has looked at fibroblast behaviour and the expression of repair-associated growth factors in tendon and bone studies, where the peptide has been associated with improved cell migration and tissue organisation in vitro.
- Convenient oral research format: Supplied as pre-measured 500 mcg capsules, this presentation supports consistent, repeatable dosing in research protocols. The pre-dosed oral format removes the handling steps required by other presentations and simplifies study design wherever an oral route of exposure is preferred.
Each of these points reflects findings from the experimental literature rather than approved indications. BPC-157 capsules are intended strictly for laboratory and research purposes and are not for human or veterinary use.
Research Data
| Research Area | Model / Setting | Reported Observation |
|---|---|---|
| Gastrointestinal protection | Rodent gastric models | Protective effect on gut lining exposed to chemical stressors |
| Tendon / ligament repair | Animal soft-tissue injury | Faster organisation of repair tissue reported |
| Angiogenesis | In vitro and animal | Upregulated VEGF expression and new vessel formation |
| Cytoprotection | Multi-organ preclinical | Stabilising effect on stressed cells described |
| Neurological models | Rodent gut-brain studies | Modulation of selected neurotransmitter pathways |
Data above is summarised from preclinical and in-vitro literature and is provided for research orientation only. It does not constitute clinical evidence of efficacy in humans.
Stack Suggestions
In research protocols, BPC-157 is sometimes studied alongside other compounds investigated for tissue and recovery endpoints, evaluated for additive or complementary effects in controlled settings:
- BPC-157 → TB-500 — paired in soft-tissue and recovery research models.
- BPC-157 → GHK-Cu — examined together in tissue-remodelling studies.
- BPC-157 → KPV — explored in gastrointestinal and inflammatory research.
⚠ Combinations are listed for research context only and do not imply safety or efficacy in humans. All pairings should follow validated protocols with appropriate controls.
Capsule Dosage Chart
| BPC-157 Capsules – 500 mcg | |
| Strength | 500 mcg (0.5 mg) per capsule |
| Bottle sizes | 30 or 60 capsules |
| Standard serving | 1 capsule once daily |
| Total content | 15 mg (30 capsules) / 30 mg (60 capsules) |
Dosage & Protocols Variations
BPC-157 Capsules supply 500 mcg per capsule (bottles of 30 or 60), dosed in whole-capsule increments and taken orally with water.
Standard Research Protocol
- Dose: 500 mcg (1 capsule)
- Duration: 4 – 6 weeks
- Frequency: 1 capsule once daily with water
- Cycle Interval: 2 – 4 weeks off before repeating
- Goal / Description: Baseline oral dosing investigated for gastrointestinal and connective tissue recovery models.
Therapeutic Research Protocol
- Dose: 1000 mcg / 1 mg (2 capsules)
- Duration: 6 – 8 weeks
- Frequency: 1 capsule twice daily, morning and evening
- Cycle Interval: 4 weeks off before repeating
- Goal / Description: Higher-dose oral regimen evaluated in models targeting tendon, ligament, and gut barrier repair.
Biohacker Protocol (experimental)
- Dose: 500 mcg (1 capsule)
- Duration: 8 – 12 weeks
- Frequency: 1 capsule once daily, continuous low-dose
- Cycle Interval: Periodic 2-week pauses
- Goal / Description: Long-term microdose protocol explored for sustained cytoprotective observations.
Possible Side Effects
BPC-157 has been described in the preclinical literature as well tolerated across the dose ranges studied in animal models, with a generally favourable safety profile reported in experimental settings. Because comprehensive controlled human safety data are not established, any conclusions about tolerability in people remain unconfirmed.
In research observations, occasional non-specific findings such as mild gastrointestinal disturbance have been noted with oral administration of peptide compounds in general. As with any investigational substance, unknown or idiosyncratic responses cannot be excluded, and the long-term safety of BPC-157 has not been formally characterised.
This product is intended strictly for laboratory and research use. It is not a medicine, is not intended for human or veterinary consumption, and must be handled only by qualified personnel following appropriate safety practices.
Product Attributes
- Compound class: Synthetic pentadecapeptide (Body Protection Compound)
- CAS #: 137525-51-0
- Molecular formula: C62H98N16O22
- Molecular weight: ~1419 g/mol
- Sequence length: 15 amino acids
- Format: Oral capsule, 500 mcg per capsule
- Status: For laboratory research use only
Scientific References
- Sikiric P, Seiwerth S, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016.
- Sikiric P, Seiwerth S, et al. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2013.
- Chang CH, Tsai WC, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011.
- Cerovecki T, Bojanic I, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019.
References are provided for research orientation only and describe preclinical or experimental work.
Included In The Box
Every order arrives in a premium, custom-designed PEPTIDE.Power box, engineered for convenience, hygiene, and safe storage. Inside, you will find everything needed for your full research protocol:
- 1× Sealed bottle of capsules, tamper-evident and ready to use — no preparation required
- Desiccant pack included to keep the capsules dry and stable
- Internal Stabilizing Foam Insert to protect the bottle during transport
- Instruction Panel printed on the inside of the box for quick reference
- Security Seal Sticker ensuring the package has not been opened or tampered with
Storage
Store the bottle in a cool, dry place away from direct light, and keep it tightly closed between uses. No refrigeration is required.
Avoid exposure to heat, humidity, and repeated temperature changes to preserve potency. Keep the desiccant pack inside the bottle.
For best results, use the product consistently within the recommended time window and always follow your research protocol.
Delivery
We ship with Next-Day EU Delivery via DHL Express or UPS Express.
All orders are prepared fresh on the day of dispatch, placed in EPS Cold-Chain Transport Boxes, and shipped with cooling elements to maintain a stable temperature throughout the journey.
Our logistics process is designed so the package arrives overnight, avoiding customs delays inside the European Union.
Products are shipped from our EU facility, ensuring no import duties, no customs clearance, and always fast and secure delivery.
Payment
Due to the nature of research peptides and the high-risk category assigned by payment processors, credit card companies do not generally support merchants in this field.
For this reason, we accept mainly Bank Transfers.
We also work with a crypto payment provider, and from time to time, card payments may be available depending on processor availability.
Within the European Union, SEPA transfers are fast, low-cost, and usually arrive within minutes to a few hours, making the payment process smooth and simple.
Once the transfer is received, your order is prepared immediately and dispatched the same day, depending on the daily cut-off time.
Please note that we do not dispatch shipments on Fridays or on days before official public holidays. This is done to ensure that parcels can be delivered on the next working day and are not held in transit over weekends or holidays.
This method ensures compliance, security, and continuity of service for all customers across the EU.
Didn't find the answer to your question?
View all frequently asked questions
